What is the recommended corticosteroid injection protocol for a 17‑year‑old with symptomatic hip bursitis after conservative treatment has failed?

Steroid Injection for Hip Bursitis in a 17-Year-Old

For a 17-year-old with hip bursitis failing conservative treatment, proceed with ultrasound-guided corticosteroid injection using 40 mg triamcinolone or methylprednisolone mixed with 4-5 mL of 1% lidocaine, ensuring proper aseptic technique and glucose monitoring if diabetic.

Injection Protocol

Corticosteroid Selection and Dosing

• Use 40 mg triamcinolone or methylprednisolone as the standard dose for hip region injections 1
• Mix with 4-5 mL of 1% lidocaine for immediate pain relief and to confirm accurate placement 2, 3
• Higher doses (80 mg) show no additional benefit over 40 mg for hip injections 1

Guidance Technique

Ultrasound guidance is recommended for several reasons 1:

• Increases injection accuracy
• Reduces procedural pain
• Allows visualization of the bursa and surrounding structures

However, if ultrasound is unavailable, landmark-guided injection remains acceptable with these caveats 2:

• Use at least a 2-inch (50.8 mm) needle to consistently reach the trochanteric bursa
• Outcomes at 2 weeks are similar between ultrasound and landmark guidance
• Ultrasound shows modest superiority only at 6 months

Aseptic Technique

Follow strict sterile protocol 4:

• Wear surgical gloves
• Prepare skin with alcohol, iodine, or chlorhexidine
• Change needles between drawing medication and injecting (draw with one needle, inject with a fresh sterile needle)
• Consider topical anesthetic (ethyl chloride spray or EMLA cream) to reduce needle pain, especially in adolescents

Expected Outcomes

Efficacy Timeline

• Short-term relief: 77% of patients report improvement at 1 week 3
• Mid-term: 69% maintain improvement at 6 weeks 3
• Long-term: 61% sustain benefit at 6 months 3
• Average therapeutic duration is approximately 4-5 months 2

Dose-Response Relationship

Higher corticosteroid doses correlate with better pain relief (p < 0.0123) 3, supporting the use of 40 mg rather than lower doses.

Critical Safety Considerations

Timing Before Surgery

If hip surgery is contemplated, maintain at least a 3-month interval between injection and any surgical procedure 4:

• Infection risk increases from 0.5% to 1.0% when injections occur within 3 months of surgery
• Beyond 3 months, infection rates return to baseline (1-2.5%)

Metabolic Monitoring

For diabetic patients, monitor blood glucose closely on days 1-3 post-injection 4:

• Transient hyperglycemia peaks during this window
• No severe events (ketoacidosis, hyperosmolar state) reported in studies
• Advise patients with suboptimal glucose control about this risk preemptively

Infection Risk

Overall infection risk is extremely low with proper technique 4:

• Approximately 0.6% in large retrospective series
• No infections reported in the included prospective studies 2, 3

Common Pitfalls to Avoid

1. Inadequate needle length: Using needles shorter than 2 inches frequently misses the bursa in landmark-guided injections 2

2. Excessive dosing: Doses above 40 mg provide no additional benefit but increase systemic exposure 1

3. Premature surgery scheduling: Waiting less than 3 months between injection and surgery doubles infection risk 4

4. Skipping local anesthetic: The lidocaine component serves dual purposes—immediate diagnostic confirmation and therapeutic benefit 5

Reinjection Considerations

If symptoms recur after initial benefit 4:

• Approximately 25% of patients relapse within 2 years 6
• Reinjection can be considered at 3-month intervals minimum
• Shared decision-making should weigh previous response against cumulative corticosteroid exposure
• Consider surgical options (iliotibial band release, bursectomy) only for truly intractable cases after multiple failed injections 7

Age-Specific Considerations

While most studies focus on older adults, the technique and dosing apply to adolescents with these modifications:

• Topical anesthetics are particularly effective in reducing procedural anxiety in younger patients 4
• Growth plate concerns are not relevant for hip bursitis (extraarticular injection)
• Conservative management should be exhausted first, but injection is appropriate when symptoms persist despite rest, NSAIDs, and physical therapy 7, 8